Category: Management

  • Describe the issue and discuss the role and impact of cost, quality, and access for obesity? Cite…

    Obesity: Issue Overview and the Roles of Cost, Quality, and Access
    Obesity is a growing global public health challenge associated with increased risk of noncommunicable diseases (cardiovascular disease, type 2 diabetes, certain cancers), reduced quality of life, and increased health system burden (WHO, 2023). Prevalence remains high and rising in many regions, with substantial variation by country, socioeconomic status, and population subgroup (CDC, 2023; WHO, 2023).
    Scope and consequences
    The health and economic consequences of obesity include higher direct medical costs (treatment, medications, procedures), indirect costs (lost productivity, disability), and broader social impacts. The economic burden is large and projected to grow unless prevention and treatment strategies are scaled up (OECD, 2019; WHO, 2023).
    Role of Cost
    Cost affects both individual-level decisions and system-level provision of obesity prevention and treatment:
    Individual affordability: Healthy foods, structured physical activity programs, behavioral interventions, and evidence-based medications or bariatric surgery often incur higher out-of-pocket costs compared with cheaper ultra-processed foods, creating a financial barrier to healthy choices (OECD, 2019).
    Health-system financing: Limited public financing for obesity prevention and long-term management can restrict availability of multidisciplinary services (dietitians, behavioral therapy, medications), leading to under-treatment (WHO, 2023).
    Macroeconomic impact: Employers and payers face higher healthcare spending and productivity losses associated with obesity, creating incentives for some payers to invest in prevention but barriers remain in translating that into accessible programs for all (OECD, 2019).
    Role of Quality
    Quality of care determines effectiveness and safety of obesity interventions:
    Evidence-based care: Access to high-quality, evidence-based services (behavioral counseling, medical therapy, bariatric surgery when indicated) improves outcomes. Poor-quality or fragmented care reduces effectiveness and may increase harm or wasted resources (Kruk et al., 2018).
    Provider training and guidelines: Variability in provider knowledge and adherence to guidelines affects the delivery of appropriate interventions and follow-up, influencing long-term success rates.
    Measurement and outcomes: High-quality systems measure outcomes, support continuity of care, and evaluate interventions for equitable effectiveness; low-quality systems fail to do so and perpetuate poor results (Kruk et al., 2018).
    Role of Access
    Access encompasses availability, geographic proximity, cultural acceptability, and insurance coverage:
    Geographic and service availability: Rural and underserved areas often lack multidisciplinary obesity services, limiting access to effective treatments.
    Insurance and coverage: Lack of coverage for nutritional counseling, pharmacotherapy, or bariatric surgery creates inequities; where coverage exists, utilization may still be low due to co-pays and prior authorization hurdles (CDC, 2023).
    Social determinants: Income, education, food environments, and built environments shape access to healthy options; policies that do not address these upstream determinants leave access barriers unaddressed (WHO, 2023).
    Interactions and Impact
    Cost, quality, and access interact: high costs and poor coverage limit access; limited access concentrates demand on low-quality or inappropriate services; and low-quality care increases long-term costs through complications and treatment failures. Together these factors perpetuate disparities in obesity prevalence and outcomes across socioeconomic and demographic groups (OECD, 2019; WHO, 2023).
    Policy and Programmatic Implications
    Increase public investment in prevention (healthy food environments, physical activity infrastructure) to reduce long-term costs and expand equitable access (WHO, 2023).
    Expand insurance coverage and reduce financial barriers for evidence-based treatments, including behavioral interventions and effective pharmacotherapies, with attention to cost-effectiveness and equity (OECD, 2019).
    Strengthen quality: implement guidelines, provider training, outcome measurement, and integrated care pathways that ensure continuity and high-quality multidisciplinary care (Kruk et al., 2018).
    Address upstream social determinants through cross-sector policies (food systems, urban planning, education) so that access to healthy options is affordable and widely available (WHO, 2023).
    Conclusions
    Addressing obesity effectively requires coordinated actions that reduce cost barriers, improve quality of care, and expand equitable access. Policies that combine prevention, high-quality treatment, and financial protections are most likely to reduce the burden of obesity and its inequities (WHO, 2023; OECD, 2019).
    References
    World Health Organization (WHO). Obesity and overweight. 2023. Available at:
    https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
    (accessed 2023).
    Centers for Disease Control and Prevention (CDC). Adult Obesity Facts. 2023. Available at:
    https://www.cdc.gov/obesity/data/adult.html
    (accessed 2023).
    Organisation for Economic Co-operation and Development (OECD). The Heavy Burden of Obesity: The Economics of Prevention. OECD, 2019. Available at:
    https://www.oecd.org/health/the-heavy-burden-of-obesity-67450d67-en.htm
    (accessed 2019).
    Kruk ME, Gage AD, Arsenault C, et al. High-quality health systems in the Sustainable Development Goals era: time for a revolution. Lancet. 2018;392(10160): 1–14. Available at:
    https://www.thelancet.com/commissions/quality-health-systems
    (accessed 2018).
    Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002. Available at:
    https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
    (accessed 2021).

  • A q, is a healthcare professional employed by a patient or patient’s family to perform nursing care…

    A q, is a healthcare professional employed by a patient or patient’s family to perform nursing care for a patient
    certified nursing assiatant
    agency nurse
    special duty nurse
    float nurse

  • Define effective communication in the context of health or community services. Why is effective…

    Define effective communication in the context of health or community services. Why is effective communication crucial for building positive relationships with clients and colleagues?

  • Order: Ampicillin,7.5mg/kg q6h IV over 20 minutes. Reconstitute medication with 2mL of 0.9% Normal…

    Order: Ampicillin,7.5mg/kg q6h IV over 20 minutes. Reconstitute medication with 2mL of 0.9% Normal Saline for IM and 150mL of 0.9% Normal Saline for IV. The Patient weighs 19lbs.
    Medication:
    Ampicillin
    Dose:
    7.5mg/kg q6h
    Route and infusion:
    IV over 20 minutes
    Reconstitution:
    2mL of 0.9% Normal Saline for IM; 150mL of 0.9% Normal Saline for IV
    Patient weight:
    19lbs

  • A patient is ștarted on losartan (Cozaar). Which is an adverse effect of this drug?A dry…

    A patient is ștarted on losartan (Cozaar). Which is an adverse effect of this drug?
    A dry nonproductive cough
    Tremors and shuffling gait
    Anorexia and constipation
    Headache and dizziness

  • identify an otc product or herbal or dietary supplement that you take and review the indications…

    ➤ How can I check for drug interactions with an OTC or herbal supplement?
    Identify the supplement’s active compound and review known interactions with prescription drugs. Watch for CYP450 inducers or inhibitors, anticoagulant effects, serotonergic activity, and blood pressure changes. Tell your pharmacist or prescriber every medication and supplement you take so they can recommend monitoring, dose adjustments, or safer alternatives.

  • A client has been diagnosed with obstructive sleep apnea osa describe obstructive sleep apnea list…

    A client has been diagnosed with obstructive sleep apnea osa describe obstructive sleep apnea list three manifestations the nurse will reinforce teaching to the client related to osa

  • How often can Methotrexate (Rheumatrex) for RA be orally administered?Select one:A. Once weekly as…

    How often can Methotrexate (Rheumatrex) for RA be orally administered?Select one:
    A. Once weekly as a single dose.
    B. Every 12 hours for three doses once weekly.
    C. Daily
    D. A or B

  • Center for Drug Evaluation and Research Quantitative Medicine Center of Excellence; Program…

    Center for Drug Evaluation and Research Quantitative Medicine Center of Excellence; Program AnnouncementU.S. Food & Drug Administration Documents / FIND; Washington, (Oct 2, 2024).

  • Not yet answeredMarked out of 1.00Flag questionThis level of prevention focuses on individuals who…

    This level of prevention focuses on individuals who are experiencing health problems or illness.
    Secondary
    Primary
    Tertiary